27825-20-3 Usage
General Description
Methyl 2-hydroxy-3-pyrazinecarboxylate is a chemical compound with the molecular formula C7H7N3O3. It is a synthetic pyrazine derivative commonly used as a flavoring agent in the food and beverage industry due to its earthy, nutty, and roasted coffee-like aroma. METHYL 2-HYDROXY-3-PYRAZINECARBOXYLATE is often added to various food products, including snacks, sauces, and beverages, to enhance their taste and aroma. Methyl 2-hydroxy-3-pyrazinecarboxylate is also used in the production of perfumes and cosmetics due to its pleasant scent. However, it is important to use this chemical in accordance with safety regulations and guidelines to prevent any potential hazards to human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 27825-20-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,8,2 and 5 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 27825-20:
(7*2)+(6*7)+(5*8)+(4*2)+(3*5)+(2*2)+(1*0)=123
123 % 10 = 3
So 27825-20-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N2O3/c1-11-6(10)4-5(9)8-3-2-7-4/h2-3H,1H3,(H,8,9)
27825-20-3Relevant articles and documents
NEW CHEMICAL COMPOUNDS
-
, (2012/04/23)
The present invention encompasses compounds of general formula (1) wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.
1H - IMIDAZO [4, 5 - C] QUINOLINES
-
Page/Page column 58, (2011/12/04)
The present invention encompasses compounds of general formula (1), wherein the groups R1 to R7, Qa, Qb, L, n and m are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations containing such compounds and their use as medicaments.
NEW CHEMICAL COMPOUNDS
-
Page/Page column 105, (2010/04/03)
The present invention encompasses compounds of general formula (1) wherein the units W, A, L, Q1 and QH are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.
